Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Background Oral anticoagulants may improve the survival of people with cancer through an
antithrombotic effect, yet increase the risk of bleeding. Objectives To evaluate the efficacy …
antithrombotic effect, yet increase the risk of bleeding. Objectives To evaluate the efficacy …
Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer
MZ Wojtukiewicz, E Sierko, LR Zacharski… - … in Thrombosis and …, 2003 - thieme-connect.com
Thromboembolism frequently complicates gastric cancer. This study examined the solid
phase interaction between gastric cancer and coagulation proteins in situ that may explain …
phase interaction between gastric cancer and coagulation proteins in situ that may explain …
Coagulation, anticoagulation and pancreatic carcinoma
IA Nakchbandi, JM Löhr - Nature Clinical Practice Gastroenterology & …, 2008 - nature.com
An increase in coagulation in patients with pancreatic carcinoma has long been
documented. In this Review, we present what is known about the pathophysiology of …
documented. In this Review, we present what is known about the pathophysiology of …
Malignancy as a solid-phase coagulopathy: implications for the etiology, pathogenesis, and treatment of cancer
LR Zacharski - Seminars in thrombosis and hemostasis, 2003 - thieme-connect.com
This overview of the coagulation biology of cancer is intended primarily for those unfamiliar
with the link between the coagulation mechanism and neoplasia. Because the literature on …
with the link between the coagulation mechanism and neoplasia. Because the literature on …
Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma
W Nakchbandi, H Müller, MV Singer… - Scandinavian journal …, 2006 - Taylor & Francis
Objective. To report the effect of regional combination chemotherapy in a cohort of patients
with inoperable pancreatic carcinoma treated with or without low-dose warfarin. Material and …
with inoperable pancreatic carcinoma treated with or without low-dose warfarin. Material and …
Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial
MZ Wojtukiewicz, L Kozlowski… - Thrombosis and …, 2003 - thieme-connect.com
Letters to the Editor of the 1Q (T2B) patients with stage III disease are alive and T of these
are diseaseJfree. Two additional living patients with stage III disease have recurred locally …
are diseaseJfree. Two additional living patients with stage III disease have recurred locally …